Ciancaglini M - Search Results

1

An overview of retinal light damage models for preclinical studies on age-related macular degeneration: identifying molecular hallmarks and therapeutic targets.

Carozza G, Zerti D, Tisi A, Ciancaglini M, Maccarrone M, Maccarone R. Carozza G, et al. Among authors: ciancaglini m. Rev Neurosci. 2023 Dec 29;35(3):303-330. doi: 10.1515/revneuro-2023-0130. Print 2024 Apr 25. Rev Neurosci. 2023. PMID: 38153807 Free article. Review.

2

Proliferative Vitreoretinopathy: A Reappraisal.

Carpineto P, Licata AM, Ciancaglini M. Carpineto P, et al. Among authors: ciancaglini m. J Clin Med. 2023 Aug 14;12(16):5287. doi: 10.3390/jcm12165287. J Clin Med. 2023. PMID: 37629329 Free PMC article. Review.

3

Topical treatment of dupilumab-associated refractory conjunctivitis and keratitis.

Di Staso F, Lambiase A, Silvio Di Staso, Gattazzo I, Ciancaglini M, Scuderi G. Di Staso F, et al. Among authors: ciancaglini m. Am J Ophthalmol Case Rep. 2022 Jan 25;25:101309. doi: 10.1016/j.ajoc.2022.101309. eCollection 2022 Mar. Am J Ophthalmol Case Rep. 2022. PMID: 35128157 Free PMC article.

4

Sweet Drugs for Bad Bugs: A Glycomimetic Strategy against the DC-SIGN-Mediated Dissemination of SARS-CoV-2.

Cramer J, Lakkaichi A, Aliu B, Jakob RP, Klein S, Cattaneo I, Jiang X, Rabbani S, Schwardt O, Zimmer G, Ciancaglini M, Abreu Mota T, Maier T, Ernst B. Cramer J, et al. Among authors: ciancaglini m. J Am Chem Soc. 2021 Oct 27;143(42):17465-17478. doi: 10.1021/jacs.1c06778. Epub 2021 Oct 15. J Am Chem Soc. 2021. PMID: 34652144

5

Persistent RNA virus infection is short-lived at the single-cell level but leaves transcriptomic footprints.

Reuther P, Martin K, Kreutzfeldt M, Ciancaglini M, Geier F, Calabrese D, Merkler D, Pinschewer DD. Reuther P, et al. Among authors: ciancaglini m. J Exp Med. 2021 Oct 4;218(10):e20210408. doi: 10.1084/jem.20210408. Epub 2021 Aug 16. J Exp Med. 2021. PMID: 34398180 Free PMC article.

6

Mastropasqua L, Lanzini M, Brescia L, D'Aloisio R, Nubile M, Ciancaglini M, D'Amario C, Agnifili L, Mastropasqua R. Mastropasqua L, et al. Among authors: ciancaglini m. Transl Vis Sci Technol. 2021 Mar 1;10(3):22. doi: 10.1167/tvst.10.3.22. Transl Vis Sci Technol. 2021. PMID: 34003957 Free PMC article.

7

Treatment of Capecitabine Corneal Side Effects With Autologous Blood-derived Serum Eye Drops.

DI Staso F, Gattazzo I, Salimbeni BT, Lambiase A, Scuderi G, DI Staso S, Ciancaglini M. DI Staso F, et al. Among authors: ciancaglini m. In Vivo. 2021 May-Jun;35(3):1881-1884. doi: 10.21873/invivo.12451. In Vivo. 2021. PMID: 33910876 Free PMC article.

8

The Impact of Oxidative Stress on Blood-Retinal Barrier Physiology in Age-Related Macular Degeneration.

Tisi A, Feligioni M, Passacantando M, Ciancaglini M, Maccarone R. Tisi A, et al. Among authors: ciancaglini m. Cells. 2021 Jan 4;10(1):64. doi: 10.3390/cells10010064. Cells. 2021. PMID: 33406612 Free PMC article. Review.

9

Ophthalmic Applications of Cerium Oxide Nanoparticles.

Maccarone R, Tisi A, Passacantando M, Ciancaglini M. Maccarone R, et al. Among authors: ciancaglini m. J Ocul Pharmacol Ther. 2020 Jul/Aug;36(6):376-383. doi: 10.1089/jop.2019.0105. Epub 2019 Dec 5. J Ocul Pharmacol Ther. 2020. PMID: 31891528 Review.

10

Anatomical and functional changes after dexamethasone implant and ranibizumab in diabetic macular edema: a retrospective cohort study.

Mastropasqua L, Di Staso S, D'Aloisio R, Mastropasqua A, Di Antonio L, Senatore A, Ciancaglini M, Di Nicola M, Di Martino G, Tognetto D, Toto L. Mastropasqua L, et al. Among authors: ciancaglini m. Int J Ophthalmol. 2019 Oct 18;12(10):1589-1597. doi: 10.18240/ijo.2019.10.11. eCollection 2019. Int J Ophthalmol. 2019. PMID: 31637195 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

109 results

Search Page